Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RY✓SelectedUSD · RYGSK vs RY performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs RY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
RY return
+334.2%
Excess return
-231.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRYExcessAlpha
1D-2.3%-1.6%-0.8%-1.7%
7D-3.0%-2.9%-0.1%-1.8%
30D+0.4%0.0%+0.4%+0.4%
3M-1.2%-8.5%+7.4%+2.3%
6M+0.9%+8.5%-7.5%-2.7%
YTD+4.0%+17.5%-13.5%-3.1%
1Y+7.3%+36.1%-28.8%-5.9%
3Y+57.1%+142.7%-85.6%+7.4%
5Y+43.0%+120.8%-77.8%+0.5%
10Y+103.1%+332.7%-229.6%+8.1%
All+103.1%+334.2%-231.1%+8.1%

Cumulative growth

Daily Returns

Daily percentage return beside RY.

Daily Out/Under-Performance

Portfolio return minus RY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling